Solid-state properties and relationship between anhydrate and monohydrate of baclofen

Area of Science:

• Solid-state chemistry
• Pharmaceutical sciences
• Materials science

Background:

• Baclofen, an antispastic agent, exhibits polymorphism with anhydrate and monohydrate crystalline forms.
• Controlling baclofen's solid state is crucial for its pharmaceutical efficacy and stability.

Purpose of the Study:

• To identify and characterize the anhydrate and monohydrate crystalline forms of baclofen.
• To investigate processing-induced phase transformations, particularly during wet granulation.
• To elucidate the interconversion pathway between baclofen's crystalline forms.

Main Methods:

• Powder X-ray diffraction (PXRD)
• Thermal analysis (e.g., DSC, TGA)
• Vibrational spectroscopy (e.g., Raman)
• Water vapor sorption analysis
• Optical microscopy
• Wet massing experiments

Main Results:

• A structural relationship between baclofen anhydrate and monohydrate was established.
• Baclofen monohydrate dehydrates to anhydrate at 60°C; anhydrate converts to monohydrate via a solvent-mediated route.
• Critical moisture levels for hydrate formation during wet granulation were identified.

Conclusions:

• The study presents a detailed interconversion pathway for baclofen's crystalline forms.
• Understanding this pathway enables better control over baclofen's solid state during manufacturing and storage.
• This knowledge is vital for ensuring consistent drug product quality and performance.